EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hepatitis Delta Virus and Hepatocellular Carcinoma

Daniele Lombardo, Maria Stella Franzè iD, Giuseppe Caminiti, Teresa Pollicino iD

Pathogens · 2024

DOI: 10.3390/pathogens13050362 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2024. Verfasst von Daniele Lombardo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University Hospital of Messina, 98124 Messina, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis Delta Virus, Liver Neoplasms, Hepatitis D. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell’Università e della Ricerca (MUR), European Union (EU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hepatitis D virus (HDV) is a compact, enveloped, circular RNA virus that relies on hepatitis B virus (HBV) envelope proteins to initiate a primary infection in hepatocytes, assemble, and secrete new virions. Globally, HDV infection affects an estimated 12 million to 72 million people, carrying a significantly elevated risk of developing cirrhosis, liver failure, and hepatocellular carcinoma (HCC) compared to an HBV mono-infection. Furthermore, HDV-associated HCC often manifests at a younger age and exhibits more aggressive characteristics. The intricate mechanisms driving the synergistic carcinogenicity of the HDV and HBV are not fully elucidated but are believed to involve chronic inflammation, immune dysregulation, and the direct oncogenic effects of the HDV. Indeed, recent data highlight that the molecular profile of HCC associated with HDV is unique and distinct from that of HBV-induced HCC. However, the question of whether the HDV is an oncogenic virus remains unanswered. In this review, we comprehensively examined several crucial aspects of the HDV, encompassing its epidemiology, molecular biology, immunology, and the associated risks of liver disease progression and HCC development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHepatitis Delta VirusLiver NeoplasmsHepatitis DHumansAnimalsHepatitis B virus

Stichwörter der Autor:innen

HBVHCCHDVchronic hepatitiscirrhosisliver disease

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University Hospital of Messina, 98124 Messina, Italy.

ORCID-Profile: Maria Stella Franzè, Teresa Pollicino

Förderung

  • Ministero dell’Università e della Ricerca (MUR)
  • European Union (EU)

Zitieren

APA

Lombardo, D., Franzè, M. S., Caminiti, G., & Pollicino, T. (2024). Hepatitis Delta Virus and Hepatocellular Carcinoma. Pathogens. https://doi.org/10.3390/pathogens13050362

Vancouver

Lombardo D, Franzè MS, Caminiti G, Pollicino T. Hepatitis Delta Virus and Hepatocellular Carcinoma. Pathogens. 2024. doi:10.3390/pathogens13050362

BibTeX
@article{Lombardo2024,
  author = {Lombardo, Daniele and Franzè, Maria Stella and Caminiti, Giuseppe and Pollicino, Teresa},
  title = {Hepatitis Delta Virus and Hepatocellular Carcinoma},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13050362}
}
Kostenlos starten →